Literature DB >> 20819066

Carbonic anhydrase inhibitors developed through 'click tailing'.

Marie Lopez1, Adam J Salmon, Claudiu T Supuran, Sally-Ann Poulsen.   

Abstract

In recent years there has been renewed activity in the literature concerning the 1,3-dipolar cycloaddition reaction (1,3-DCR) of organic azides (R-N₃) with alkynes (R'-C≡CH) to form 1,2,3-triazoles, i.e. the Huisgen synthesis. The use of catalytic Cu(I) leads to a dramatic rate enhancement (up to 10(7)-fold) and exclusive synthesis of the 1,4-disubstituted 1,2,3-triazole product. The reaction, now referred to as the copper-catalyzed azide-alkyne cycloaddition (CuAAC), meets the stringent criteria of a click-reaction in that it is modular, wide in scope, high yielding, has no byproducts, operates in water at ambient temperature, product purification is simple and the starting materials are readily available. The 1,3-DCR reaction has rapidly become the premier click chemistry reaction with applications spanning modern chemistry disciplines, including medicinal chemistry. Recently the 'tail' approach initiative for the development of carbonic anhydrase inhibitors (CAIs) has been combined with the synthetic versatility of click chemistry. This has proven a powerful combination leading to the synthesis of CAIs with useful biopharmaceutical properties and activities. This review will discuss complementary and contrasting applications that have utilized 'click tailing' for the development of CAIs. Applications encompass i) medicinal chemistry and drug discovery; ii) radiopharmaceutical development of positron emission topography (PET) chemical probes; and iii) in situ click chemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819066     DOI: 10.2174/138161210793429869

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  10 in total

1.  Synthesis of saccharin-glycoconjugates targeting carbonic anhydrase using a one-pot cyclization/deprotection strategy.

Authors:  Akilah B Murray; Marta Quadri; Haoxi Li; Robert McKenna; Nicole A Horenstein
Journal:  Carbohydr Res       Date:  2019-03-19       Impact factor: 2.104

2.  Carbonic Anhydrase Glycoinhibitors belonging to the Aminoxysulfonamide Series.

Authors:  Joanna Ombouma; Daniella Vullo; Pascal Dumy; Claudiu T Supuran; Jean-Yves Winum
Journal:  ACS Med Chem Lett       Date:  2015-06-02       Impact factor: 4.345

3.  Saccharin: a lead compound for structure-based drug design of carbonic anhydrase IX inhibitors.

Authors:  Brian P Mahon; Alex M Hendon; Jenna M Driscoll; Gregory M Rankin; Sally-Ann Poulsen; Claudiu T Supuran; Robert McKenna
Journal:  Bioorg Med Chem       Date:  2014-12-23       Impact factor: 3.641

Review 4.  Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer.

Authors:  Kathryn F Tonissen; Sally-Ann Poulsen
Journal:  Cancer Drug Resist       Date:  2021-06-19

Review 5.  Tailored therapeutics based on 1,2,3-1H-triazoles: a mini review.

Authors:  Parteek Prasher; Mousmee Sharma
Journal:  Medchemcomm       Date:  2019-05-14       Impact factor: 3.597

6.  Synthesis of Novel Saccharin Derivatives.

Authors:  Gregory M Rankin; Sally-Ann Poulsen
Journal:  Molecules       Date:  2017-03-23       Impact factor: 4.411

7.  Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails.

Authors:  Fadi M Awadallah; Silvia Bua; Walaa R Mahmoud; Hossam H Nada; Alessio Nocentini; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

8.  Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile.

Authors:  Tatiana Sharonova; Petr Zhmurov; Stanislav Kalinin; Alessio Nocentini; Andrea Angeli; Marta Ferraroni; Mikhail Korsakov; Claudiu T Supuran; Mikhail Krasavin
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

9.  The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors-A Spin-Off Discovery from Fragment Screening.

Authors:  Sarah L Mueller; Panagiotis K Chrysanthopoulos; Maria A Halili; Caryn Hepburn; Tom Nebl; Claudiu T Supuran; Alessio Nocentini; Thomas S Peat; Sally-Ann Poulsen
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

10.  Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.

Authors:  P V Sri Ramya; Srinivas Angapelly; Andrea Angeli; Chander Singh Digwal; Mohammed Arifuddin; Bathini Nagendra Babu; Claudiu T Supuran; Ahmed Kamal
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.